Morton's neuroma in the foot
Conditions
Interventions
Participants will be randomized into two groups. The study group with 25 participants will be submitted to three applications (one per week) with 2ml of Hyaluronic Acid. The control group with 25 part
Sponsors
Instituto Prevent Senior
Instituto Prevent Senior
Eligibility
Age
16 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with a clinical diagnosis of Morton's Neuroma confirmed by an ultrasound examination, attended at the outpatients of the group's researchers and signed the informed consent form.
Exclusion criteria
Exclusion criteria: Patients with neuropathy, skin lesions, previous degenerative injuries to the ankle or previous surgeries on the ankle or Achilles tendon, previous allergy to sodium hyaluronate, allergies to avian proteins, less than 16 years of age, sequelae of tibial pylon fractures, ankle and foot. In addition, patients with collagen disorders, rheumatoid arthritis, seronegative arthritis will be excluded. Patients with previous infiltration will also be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study is to compare pain using VAS when applying sodium hyaluronate to Morton's Neuroma compared to using corticosteroids. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoint of the study is to compare personal satisfaction through the Coughlin score after the application of sodium hyaluronate for Morton's Neuroma compared to the application of corticosteroid. | — |
Countries
Brazil
Contacts
Public ContactGabriel Ferreira
Outcome results
None listed